ALDH1A1 and breast cancer: Cumulative evidence has revealed that aberrant expression of ALDH1 is being evaluated as a potential novel prognostic marker in breast cancer (13), head and neck squamous cell carcinoma (7), ovarian cancer (9), and lung cancer (14).